ISRG · XBRL financial data

Intuitive Surgical financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (ISRG's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Revenue from contracts with customers	1,928*	1,891	2,010	2,038	2,414*	2,253	2,440	2,505	2,866*	2,771	2,892	3,049
Cost of goods and services sold	651*	645	637	664	771*	796	822	843	962*	940	932	964
Gross profit	1,277*	1,245	1,373	1,374	1,642*	1,458	1,618	1,662	1,904*	1,831	1,960	2,084
Research and development	260*	285	280	286	295*	316	313	329	353*	362	371	408
Selling, general and administrative	567*	492	525	511	613*	563	561	573	687*	613	618	633
Total operating expenses	827*	776	805	797	907*	880	875	903	1,040*	975	989	1,492
Operating income (loss)	450*	469	567	577	735*	578	743	760	864*	855	972	593
Income tax expense (benefit)	(95)*	(9)	123	100	122*	(35)	168	146	156*	114	231	144
Net income (loss)	606*	545	527	565	686*	698	658	704	795*	822	818	523
Earnings per share, basic USD per share	1.72*	1.54	1.48	1.59	1.92*	1.95	1.84	1.98	2.24*	2.31	2.31	1.50
Earnings per share, diluted USD per share	1.69*	1.51	1.46	1.56	1.88*	1.92	1.81	1.95	2.21*	2.28	2.29	1.49
Weighted average shares, basic millions of shares	352*	354	355	356	356*	358	359	357	355*	355	354	349
Weighted average shares, diluted millions of shares	358*	361	361	363	364*	365	364	362	360*	360	357	352

Balance sheet

CSV

Fiscal quarters (ISRG's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Cash and cash equivalents	2,750	2,840	3,037	2,413	2,027	2,574	3,403	2,807	3,368	2,007	2,760	2,978
Marketable securities	2,473	1,961	1,721	1,818	1,986	1,938	1,923	2,102	2,567	2,511	2,456	1,064
Marketable securities, non-current	2,120	2,523	2,926	4,080	4,819	4,590	4,206	3,524	3,099	3,462	3,409	2,758
Accounts receivable	1,130	1,128	1,109	1,153	1,225	1,222	1,269	1,260	1,527	1,596	1,673	1,721
Inventory	1,221	1,299	1,384	1,482	1,487	1,554	1,667	1,782	1,840	1,945	2,029	2,128
Prepaid and other current assets	314	405	404	349	385	371	483	575	477	752	625	536
Total current assets	7,888	7,633	7,654	7,216	7,111	7,658	8,746	8,525	9,780	8,810	9,543	8,428
Property and equipment, net	3,538	3,800	4,117	4,433	4,647	4,799	4,985	5,151	5,342	5,448	5,552	5,676
Right-of-use asset	79	—	—	—	136	—	—	—	151	—	—	—
Goodwill	349	348	348	348	348	348	349	348	370	613	581	558
Total assets	15,442	15,828	16,650	17,743	18,743	19,220	20,163	19,352	20,459	20,111	20,877	19,349
Accounts payable	189	194	194	219	193	276	267	291	255	333	277	280
Total current liabilities	1,659	1,375	1,488	1,677	1,745	1,538	1,693	1,803	2,006	1,911	1,923	2,533
Lease liability, non-current	65	—	—	—	113	—	—	—	132	—	—	—
Total liabilities	2,044	1,782	1,853	2,066	2,214	2,013	2,210	2,310	2,517	2,514	2,579	3,231
Retained earnings	4,743	5,068	5,582	6,130	6,803	7,139	7,606	6,424	7,012	6,398	6,837	4,525
Total stockholders' equity	13,308	13,963	14,708	15,583	16,434	17,106	17,846	16,930	17,824	17,475	18,168	15,986
Total liabilities and equity	15,442	15,828	16,650	17,743	18,743	19,220	20,163	19,352	20,459	20,111	20,877	19,349
Common shares outstanding (cover page) millions of shares	352	355	355	356	357	358	358	354	355	354	353	347

Cash flows

CSV

Fiscal quarters (ISRG's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Net income (loss)	606*	545	527	565	686*	698	658	704	795*	822	818	523
Stock-based compensation	150*	153	174*	173*	177*	185	196*	204*	203*	210	210*	213*
Net cash from operating activities	228*	265	621*	707*	823*	582	715*	841*	893*	912	1,061*	1,224*
Net cash from investing activities	(1,044)*	(129)	(467)*	(1,413)*	(1,264)*	214	261*	401*	(209)*	(915)	(27)*	1,898*
Share repurchases	66*	0	0*	0*	0*	0	181*	1,913*	201*	1,123	320*	2,976*
Dividends paid	—	—	—	0*	—	—	—	0*	—	—	—	—
Net cash from financing activities	(32)*	(47)	50*	98*	49*	(236)	(148)*	(1,843)*	(138)*	(1,354)	(288)*	(2,894)*
Net change in cash	(853)*	97	200*	(621)*	(384)*	555	829*	(597)*	558*	(1,355)	754*	217*

Compare with peers

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Intuitive Surgical	2,978	3,049	1,224*	346.6M	—	Q3 FY26 10-QSep 30, 2026
Boston Scientific	609	5,138	1,048*	1.4B	—	Q3 FY26 10-QSep 30, 2026
Stryker	3,271	6,520	1,461*	380.7M	—	Q3 FY26 10-QSep 30, 2026
Medtronic	1,691	9,756	1,793	1.3B	—	Q1 FY27 10-QJul 31, 2026
3M	4,835	6,584	486*	516.7M	—	Q3 FY26 10-QSep 30, 2026
Becton Dickinson	708	4,983	not reported	272.4M	—	Q3 FY26 10-QJun 30, 2026
MiniMed Group	207	843	(49)	281.3M	2.3 quarters	Q1 FY27 10-QJul 31, 2026
Edwards Lifesciences	2,907	1,741	652*	576.4M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.